Tổng hợp dẫn xuất 8-hydroxyquinoline-6-carboxamide
Abstract
Tóm tắt
Article Details
Tài liệu tham khảo
Abdel-Moty et al., 2005, Synthesis of some quinoline thiosemicarbazone derivatives of potential antimicrobial activity, Bull. Pharm. Sci (Assiut University) 28, 79–93.
Andrew et al., 2008, J. Org. Chem., 73, 1911-1918.
Bahareh et al., 2011, Res. J. Pharm., Bio. and Chem. Sci.,2, 62.
Châu Nguyễn Trầm Yên và Bùi Thị Bửu Huê, 2012, Tổng hợp dẫn xuất 4-Oxo-4H-Quinolizine-2-carboxamide, Tạp chí Hóa học, Viện Khoa học và Công nghệ Việt Nam, 50(5A) 105-108.
Dardari et al., 2004, Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5-(3’-phenylisoxazolino) methyl]-8-hydroxyquinoline: preliminary study, Farmaco, 59, 195–199.
Elias et al., 2002, Eur. J. Org. Chem., 3341-3350.
Goda et al., 2005, Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study, Bioorg. Med. Chem. 13, 3175–3183.Silverman, 1992, Organic Chemistry of Drug Design and Drug Action, Academic Press, San Diego.
Hans Stobbe, 1899, Ann., 308, 89.
Hazeldine et al., 2005, Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-4-[(7-chloro-2-quinoxalinyl)oxy]phenoxypropionic acid, and 2-4-[7-bromo-2-quinolinyl)-oxy]phenoxypropionic acid, Bioorg. Med. Chem. 13, 1069–1081.
He et al., 2005, Design, synthesis, and biological evaluation of novel 4-hydro-quinoline-3-carboxamide derivatives as an immunomodulator, Bioorg. Med. Chem. Lett. 15, 2980–2985.
Izidor Sosič et al., 2013, Development of New Cathepsin B Inhibitors: Combining Bioisosteric Replacements and Structure-Based Design To Explore the Structure−Activity Relationships of Nitroxoline Derivatives J. Med. Chem., 56, 521−533.
Kravchenko et al., 2005, 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors, Bioorg. Med. Chem. Lett., 15, 1841–1845.
Mirkovίc et al., 2011, J. Chem. Med. Chem., 6, 1351−1356.
Motasim Billah et al., 2002, Pharmacology of N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor, The Journal of Pharmacology and Experimantal Therapeutics, Vol. 302, No. 1, 127-137.
Normand-Bayle et al., 2005, New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity, Bioorg. Med. Chem. Lett., 15, 4019–4022.
Savini et al., 2001, Synthesis and pharmacological activity of 1,2,4-triazolo[4,3-a]quinolines, Farmaco 56, 939–945.
Simon David Guile and Toby Thompson, 2012, United States Patent. Patent No.: US 8,106,073 (45) Date of Patent: Jan. 31.
Stanislav Gobec, 2013, J. Med. Chem., 56, 521−533.
Stephen H. Dunn and Alexander McKillop, 1993, Synthesis of Norsegoline, J. Chem. Soc. Perkin Trans. I, 879-880.
Vlahov et al., 1990, Synthesis of some new quinoline derivatives – potential antimalarial drugs, Pure Appl. Chem., 62, 1303–1306.